AdvaMed Urges Biden Administration To Use CHIPS To Prioritize Patient Care
Now that the CHIPS and Science Act is law, AdvaMed wants the Biden administration to use it to ensure device makers get the semiconductor chips they need for their products while preventing the US from facing another shortage of the essential components, as experienced during the pandemic.
You may also be interested in...
The annual address also included discussion of legislation passed to improve the US supply of semiconductor chips, as well as new research body ARPA-H.
The US Food and Drug Administration is alerting health care providers that some cardiac devices from a major supplier are in short supply.
In a bipartisan vote, the US Congress passed legislation that allocates billions of dollars to domestic manufacturers of semiconductor chips – essential components in a myriad of products, including many medical devices.